The ability of current biologics law to accommodate emerging technologies.
Carter
M J
MJ
D001688:Biological Products; D001709:Biotechnology / Q000331:legislation & jurisprudence / Q000639:trends; D017690:Cell Transplantation / Q000331:legislation & jurisprudence / Q000639:trends; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005544:Forecasting; D015316:Genetic Therapy / Q000331:legislation & jurisprudence / Q000639:trends; D006801:Humans; D007880:Legislation, Drug / Q000639:trends; D014183:Transplantation, Heterologous; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D001688:Biological Products